Drugs such as Ozempic and other GLP-1s may interfere with medical scan results

Researchers have revealed a stunning new facet impact linked to GLP-1 agonists, comparable to Ozempic, Wegovy, Mounjaro and Zepbound.

These common therapies for diabetes and weight problems can intervene with medical imaging comparable to PET and CT (“CAT”) scans.

CT scans are sometimes used to acquire detailed inside photographs to detect accidents, tumors or different abnormalities, in accordance with Cleveland Clinic. A typical use of PET scans is to look at organs and tissues, detect most cancers exercise, or monitor how the physique responds to remedy.

DANGEROUS ‘GRAY MARKET’ WEIGHT LOSS DRUGS FLOOD US AS EXPERTS WARN OF RISKS

Within the case assessment, offered this week on the thirty eighth annual congress of the European Affiliation of Nuclear Medication in Barcelona, ​​Spain, researchers analyzed most cancers scans of sufferers taking GLP-1 medication, in accordance with a press launch.

They discovered some ‘atypical’ scan outcomes that might be mistaken as indicators of illness.

Well-liked therapies for diabetes and weight problems can intervene with medical imaging comparable to PET and CT scans, a research suggests. (iStock)

“We famous an uncommon uptake of a GLP-1 agonist in one in every of our sufferers, prompting a broader assessment inside our community,” mentioned lead creator Dr. Peter Strouhal, medical director at Alliance Medical Ltd in the UK, mentioned within the press launch.

“We discovered that these altering patterns have gotten more and more widespread, however there are at the moment no nationwide or worldwide pointers within the UK to deal with this rising drawback.”

“It is one thing we’ll be being attentive to in our trade, however extra info is required.”

Misunderstanding these scan outcomes can result in further testing, incorrect most cancers assessments and delays in remedy, which might trigger stress and anxiousness for sufferers, the discharge mentioned.

“Understanding how GLP-1 medication can have an effect on scan photographs helps physicians keep away from confusion and pointless procedures in order that sufferers obtain the suitable care shortly and confidently,” mentioned Strouhal.

“We seen an uncommon uptake in one in every of our sufferers on a GLP-1 agonist, which prompted a broader assessment inside our community,” mentioned the research’s lead creator. (iStock)

Regardless of these findings, the researchers mentioned they don’t advocate sufferers cease taking GLP-1s earlier than present process a scan, however they did emphasize that imaging groups ought to take sufferers’ treatment use into consideration when deciphering scan outcomes.

Wanting forward, the analysis group plans to gather extra knowledge from world imaging facilities to strengthen these findings.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Sue Decotiis, MD, a medical weight-loss doctor in New York Metropolis, identified that the research outcomes are nonetheless very preliminary.

“They only seen a rise, however it did not point out which organs or particular physique elements,” Decotis, who was not concerned within the research, informed Fox Information Digital.

Researchers mentioned they don’t seem to be recommending that sufferers cease taking GLP-1s earlier than present process a scan, however they did emphasize that imaging groups ought to take sufferers’ treatment use into consideration when deciphering scan outcomes. (iStock)

See also  Michigan Lottery Daily 3, Daily 4 results for Jan. 9, 2026

“Will probably be essential to see extra knowledge from many extra sufferers to grasp precisely what they noticed. It is one thing we’ll control in our trade, however extra info is required.”

Adam Wolfberg, MD, chief medical officer at Virta Well being in Massachusetts, additionally mirrored on the research.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“GLP-1s have many results on the physique, and one in every of them adjustments the way in which glucose is metabolized,” Wolfberg, who additionally didn’t take part within the research, informed Fox Information Digital. “For the reason that tracer agent utilized in these PET scans comprises glucose, the absorption of the agent – a kind of metabolic ‘dye’ – could also be affected.”

“Interpretation of the corresponding photographs would require data of this medical background.”

“Understanding how GLP-1 medication can have an effect on scan photographs may also help docs keep away from confusion and pointless procedures so sufferers get the suitable care shortly and confidently,” he mentioned. (iStock)

Nevertheless, he reiterated that he doesn’t take into account this discovering “a significant drawback.”

“PET scans are all the time interpreted within the context of the entire affected person,” Wolfberg mentioned. “An skilled oncologist or radiologist all the time takes into consideration a affected person’s medical historical past and medicines they’re taking when studying one of these scan.”

For extra well being articles, go to www.foxnews.com/well being

Wolfberg agreed that rather more knowledge could be wanted earlier than these observations would influence medical apply.

Fox Information Digital reached out to the researchers for remark, in addition to producers of GLP-1 medication.